TB following targeted and biological therapy: can we predict it?

J. Cafferkey (London, United Kingdom), S. Kostich (London, United Kingdom), P. Jewell (London, United Kingdom), M. Patel (London, United Kingdom), M. Park (London, United Kingdom), T. Harris (London, United Kingdom), G. Canales (London, United Kingdom), G. Russell (London, United Kingdom), O. Kon (London, United Kingdom), L. Martin (London, United Kingdom)

Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Session: Tuberculosis and comorbidities
Session type: E-poster session
Number: 487
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Cafferkey (London, United Kingdom), S. Kostich (London, United Kingdom), P. Jewell (London, United Kingdom), M. Patel (London, United Kingdom), M. Park (London, United Kingdom), T. Harris (London, United Kingdom), G. Canales (London, United Kingdom), G. Russell (London, United Kingdom), O. Kon (London, United Kingdom), L. Martin (London, United Kingdom). TB following targeted and biological therapy: can we predict it?. 487

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: